Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae: a Multicenter Case-control Study.

NCT04671290 is registered in ClinicalTrials.gov with Centre Hospitalier Annecy Genevois as lead sponsor.

NCT NCT04671290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae: a Multicenter Case-control Study.
Lead sponsor
Centre Hospitalier Annecy Genevois
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
October 31, 2019
Enrollment
144 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

urinary tract infection bacterial